Internal U.S. Army memo flags 'fundamental security' vulnerabilities in a key battlefield communications network, raising contract concerns.
Shares of the recently-listed marine fuel provider hit all-time lows on massive volume as the market reacts to unspecified executive shifts.
Blaze at the massive El Segundo facility, a key fuel supplier for Southern California, raises concerns over potential price impacts.
The sale of the controlling interest in the insurance platform represents a significant and rapid return on investment for White Mountains.
Settlement with Dr. Reddy's Laboratories shields key drugs NEXLETOL and NEXLIZET from generic competition until 2040, boosting investor confidence.
With a potential market of 128 million in the U.S., analysts see blockbuster potential for the new presbyopia treatment.
Governor Newsom's signature on AB30 is expected to expand the ethanol market by over 600 million gallons annually.
Positive Phase 1 results for the company's epilepsy drug candidate are coupled with a significant financing deal that could dilute shares.